Fidelity Investments’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Fidelity Investments’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,526,841	Closed	-$264M	–	2895
2015 Q1	$264M	Buy	1,526,841 +158,406	+12%	+$23.3M	0.03%	565
2014 Q4	$157M	Sell	1,368,435 -4,036,210	-75%	-$489M	0.02%	786
2014 Q3	$844M	Sell	5,404,645 -1,264,998	-19%	-$183M	0.11%	188
2014 Q2	$823M	Sell	6,669,643 -1,190,004	-15%	-$132M	0.11%	196
2014 Q1	$814M	Buy	7,859,647 +323,352	+4%	+$33.1M	0.11%	188
2013 Q4	$678M	Buy	7,536,295 +5,680,431	+306%	+$453M	0.1%	231
2013 Q3	$124M	Buy	1,855,864 +352,859	+23%	+$24.3M	0.02%	851
2013 Q2	$99.4M	Buy	+1,503,005	New	+$86M	0.02%	916

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

Fidelity Investments's SLXP Position: Q2 2015 in Review

Fidelity Investments sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,526,841 shares — an estimated $264M sold.

Fidelity Investments first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $844M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Fidelity Investments reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Fidelity Investments sold 1,526,841 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $264M.
Fidelity Investments first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Fidelity Investments's SALIX PHARMACEUTICALS LTD DEL position peaked at $844M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Fidelity Investments's 13F filing for Q2 2015, filed 13 Aug 2015.